Table 4 Changes in body weight control and experimental groups of mice.
No. | Groups | Number of weeks Body weight of mice(g) | ||||
|---|---|---|---|---|---|---|
0 | 2 | 4 | 6 | 8 | ||
(I) | Normal control | 35.23 ± 0.36 | 36.40 ± 0.52 | 37.96 ± 0.69 | 38.80A ± 3.68 | 40.65 AB ± 1.31 |
(II) | PCOS-induced group [HFD + Letrozole (90 µg /kg.b.w.)] | 34.69 ± 0.377 | 36.88 ± 0.96 | 40.29 a AB ± 1.39 | 45.43 a ABC ± 2.69 | 51.93 a ABCD ± 2.012 |
(III) | PCOS + MTF (500 mg/kg.b.w.) | 34.72 ± 0.92 | 35.193 ± 0.87 | 35.32 b ± 0.61 | 41.38 ab A ± 0.511 | 47.83 ab AD ± 2.08 |
(IV) | PCOS + MTL (500 mg/kg.b.w.) | 34.62 ± 1.08 | 35.32 ± 1.24 | 36.29 b ± 0.88 | 38.19 bc ± 1.03 | 44.39 abc ± 1.16 |
(V) | PCOS + MVF (500 mg/kg.b.w.) | 37.50 ± 0.60 | 36.04 ± 0.46 | 37.70 b ± 0.90 | 40.12 d A ± 0.40 | 46.46 ab ABCD ± 0.98 |
(VI) | PCOS + MVL (500 mg/kg.b.w.) | 35.92 ± 1.48 | 34.08 ± 1.66 | 35.93 b ± 0.25 | 36.16 bce ± 0.25 | 39.25 abcde ABCD ± 0.65 |
(VII) | PCOS + Metformin (300 mg/kg.b.w.) | 35.50 ± 0.71 | 33.63 ± 1.677 | 35.25 b ± 1.35 | 37.72 bce ± 0.98 | 37.72 abcde ± 0.98 |
| Â | F | 1.28* | 5.76* | 11.93* | 16.43* | 21.74* |
p | < 0.05* | < 0.05* | < 0.05* | < 0.05* | < 0.05* | |